NIMGenetics SL - Company Review
NIMGenetics SL - Company ReviewSummary
NIMGenetics SL (NIMGenetics) is a biomedical company that designs and commercializes products and services for clinical genetic diagnosis. The company develops genomic products and services using two technologies such as microarrays and next-generation sequencing. Its products include karyonim 60K, onconim seq BRCA1/BRCA, karyonim autism 180K, onconim seq409 and onconim familial colon cancer, among others. NIMGenetics serves various therapeutic areas such as gynecology, pediatrics and oncology. The company performs research in the area of genomics. It offers a range of services for research such as CGH arrays, expression arrays, methylation arrays, chip-on-chip arrays, and others. The company collaborates and develops research projects with various institutes across the world. NIMGenetics is headquartered in Madrid, Spain.
This comprehensive company report of NIMGenetics SL provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.